Last updated on April 2019

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)


Brief description of study

An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

Detailed Study Description

Primary

To evaluate the long-term safety and tolerability of seladelpar

Secondary

To evaluate the long-term efficacy of seladelpar

Clinical Study Identifier: NCT03301506

Find a site near you

Start Over

Stanford Healthcare

Palo Alto, CA United States
  Connect »

Mercy Medical Center

Baltimore, MD United States
  Connect »

Saint Louis University

Saint Louis, MO United States
  Connect »

NYU Langone Health

New York, NY United States
  Connect »

Baylor College of Medicine

Houston, TX United States
  Connect »

Pinnacle Clinical Research

Live Oak, TX United States
  Connect »

Maryview Hospital Inc.

Newport News, VA United States
  Connect »

Plymouth Hospital

Plymouth, United Kingdom
  Connect »